ClinicalTrials.gov
public full text
Public Domain
Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases
Octagam is a human normal immunoglobulin (IGIV) solution for intravenous administration. Octagam 5% is currently registered in more than 60 countries. This study will evaluate the efficacy, safety and the kinetics of Octagam 10% for replacement therapy in primary immunodeficiency diseases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- iHIVARNA Clinical Trial in HIV Infected Individuals#398187
- Clinical data for primary immunodeficiency patients#260345
- Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)#828281
- Single Dose Truvada in HIV-negative Men and Women#856065
- Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers#867606
Record · ID 843098
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive